An Interim Analysis of Phase II, Open Randomized Comparative Trial: Alternate or Multiple-Day Dosing of Palonosetron (PALO) Is Effective and Safe in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients (pts) with Leukemia Receiving High Dose Ara-C (HDAC).
Title:
An Interim Analysis of Phase II, Open Randomized Comparative Trial: Alternate or Multiple-Day Dosing of Palonosetron (PALO) Is Effective and Safe in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients (pts) with Leukemia Receiving High Dose Ara-C (HDAC).
Author:
Mattiuzzi, Gloria Cortes, Jorge Cassat, Jennifer Blamble, Deborah Bekele, B. Nebiyou Beran, Miloslav Borthakur, Gautam Ravandi, Farhad Burger, Jan Kantarjian, Hagop